-
1
-
-
0026762721
-
Prospective analysis of the insulin-resistance syndrome (syndrome x)
-
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome x). Diabetes 1992;41:715-722.
-
(1992)
Diabetes
, vol.41
, pp. 715-722
-
-
Haffner, S.M.1
Valdez, R.A.2
Hazuda, H.P.3
Mitchell, B.D.4
Morales, P.A.5
Stern, M.P.6
-
2
-
-
0035897696
-
Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii)
-
Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA 2001;285:2486-2497.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
3
-
-
0037407403
-
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older
-
DOI 10.2337/diabetes.52.5.1210
-
Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Ncep-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among nhanes iii participants age 50 years and older. Diabetes 2003;52:1210-1214. (Pubitemid 36523358)
-
(2003)
Diabetes
, vol.52
, Issue.5
, pp. 1210-1214
-
-
Alexander, C.M.1
Landsman, P.B.2
Teutsch, S.M.3
Haffner, S.M.4
-
4
-
-
33644849140
-
Metabolic syndrome-definition and diagnostic criteria in japan
-
Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in japan. J Atheroscler Thromb 2005;12:301.
-
(2005)
J Atheroscler Thromb
, vol.12
, pp. 301
-
-
Matsuzawa, Y.1
-
5
-
-
0037021505
-
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
-
DOI 10.1001/jama.288.21.2709
-
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle- aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.21
, pp. 2709-2716
-
-
Lakka, H.-M.1
Laaksonen, D.E.2
Lakka, T.A.3
Niskanen, L.K.4
Kumpusalo, E.5
Tuomilehto, J.6
Salonen, J.T.7
-
6
-
-
71049179735
-
The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: The japan public health center-based study
-
Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: The japan public health center-based study. Hypertens Res 2009;32:289-298.
-
(2009)
Hypertens Res
, vol.32
, pp. 289-298
-
-
Noda, H.1
Iso, H.2
Saito, I.3
Konishi, M.4
Inoue, M.5
Tsugane, S.6
-
7
-
-
0041508599
-
Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome
-
DOI 10.1016/S0002-9149(03)00736-7
-
Messerli AW, Seshadri N, Pearce GL, Sachar R, Hoogwerf BJ, Sprecher DL. Relation of albumin/creatinine ratio to c-reactive protein and to the metabolic syndrome. Am J Cardiol 2003;92: 610-612. (Pubitemid 37013421)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.5
, pp. 610-612
-
-
Messerli, A.W.1
Seshadri, N.2
Pearce, G.L.3
Sachar, R.4
Hoogwerf, B.J.5
Sprecher, D.L.6
-
8
-
-
0037469255
-
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy american women
-
Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy american women. Circulation 2003;107:391-397.
-
(2003)
Circulation
, vol.107
, pp. 391-397
-
-
Ridker, P.M.1
Buring, J.E.2
Cook, N.R.3
Rifai, N.4
-
9
-
-
1642460647
-
C-Reactive Protein Modifies the Relationship between Blood Pressure and Microalbuminuria
-
DOI 10.1161/01.HYP.0000120125.08867.42
-
Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO, de Zeeuw D. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004;43:791-796. (Pubitemid 38405589)
-
(2004)
Hypertension
, vol.43
, Issue.4
, pp. 791-796
-
-
Stuveling, E.M.1
Bakker, S.J.L.2
Hillege, H.L.3
Burgerhof, J.G.M.4
De Jong, P.E.5
Gans, R.O.B.6
De Zeeuw, D.7
-
10
-
-
20944436880
-
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients
-
DOI 10.1111/j.1365-2796.2005.01468.x
-
Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Parodi A, Falqui V, Tomolillo C, Deferrari G, Pontremoli R. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 2005;257: 454-460. (Pubitemid 40613071)
-
(2005)
Journal of Internal Medicine
, vol.257
, Issue.5
, pp. 454-460
-
-
Leoncini, G.1
Ratto, E.2
Viazzi, F.3
Vaccaro, V.4
Parodi, D.5
Parodi, A.6
Falqui, V.7
Tomolillo, C.8
Deferrari, G.9
Pontremoli, R.10
-
11
-
-
35948938513
-
The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese
-
DOI 10.1016/j.metabol.2007.07.015, PII S0026049507002776
-
Lee IT, Lee WJ, Huang CN, H-H Sheu W. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic taiwanese. Metabolism 2007;56:1708-1713. (Pubitemid 350064590)
-
(2007)
Metabolism: Clinical and Experimental
, vol.56
, Issue.12
, pp. 1708-1713
-
-
Lee, I.-T.1
Lee, W.-J.2
Huang, C.-N.3
H-H Sheu, W.4
-
12
-
-
56049091755
-
Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study
-
Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 2008; 26:2198-2206.
-
(2008)
J Hypertens
, vol.26
, pp. 2198-2206
-
-
Halimi, J.M.1
Bonnet, F.2
Lange, C.3
Balkau, B.4
Tichet, J.5
Marre, M.6
-
13
-
-
71049178305
-
Association of metabolic syndrome with urinary albumin excretion, low-grade inflammation, and low glomerular filtration rate among nondiabetic japanese subjects
-
Abe R, Minami J, Ohrui M, Ishimitsu T. Association of metabolic syndrome with urinary albumin excretion, low-grade inflammation, and low glomerular filtration rate among nondiabetic japanese subjects. Intern Med 2009;48:1855-1862.
-
(2009)
Intern Med
, vol.48
, pp. 1855-1862
-
-
Abe, R.1
Minami, J.2
Ohrui, M.3
Ishimitsu, T.4
-
14
-
-
65649145291
-
Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
-
Solbu MD, Kronborg J, Jenssen TG, Njolstad I, Lochen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 2009;204:503-508.
-
(2009)
Atherosclerosis
, vol.204
, pp. 503-508
-
-
Solbu, M.D.1
Kronborg, J.2
Jenssen, T.G.3
Njolstad, I.4
Lochen, M.L.5
Mathiesen, E.B.6
Wilsgaard, T.7
Eriksen, B.O.8
Toft, I.9
-
15
-
-
21744442905
-
New definition of microalbuminuria in hypertensive subjects: Association with incident coronary heart disease and death
-
DOI 10.1161/01.HYP.0000169153.78459.50
-
Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: Association with incident coronary heart disease and death. Hypertension 2005;46:33-37. (Pubitemid 40946487)
-
(2005)
Hypertension
, vol.46
, Issue.1
, pp. 33-37
-
-
Klausen, K.P.1
Scharling, H.2
Jensen, G.3
Jensen, J.S.4
-
16
-
-
68749092947
-
Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban japanese population with and without chronic kidney disease: The suita study
-
Kokubo Y, Nakamura S, Okamura T, Yoshimasa Y, Makino H, Watanabe M, Higashiyama A, Kamide K, Kawanishi K, Okayama A, Kawano Y. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban japanese population with and without chronic kidney disease: The suita study. Stroke 2009;40:2674-2679.
-
(2009)
Stroke
, vol.40
, pp. 2674-2679
-
-
Kokubo, Y.1
Nakamura, S.2
Okamura, T.3
Yoshimasa, Y.4
Makino, H.5
Watanabe, M.6
Higashiyama, A.7
Kamide, K.8
Kawanishi, K.9
Okayama, A.10
Kawano, Y.11
-
17
-
-
0036788492
-
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
-
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-1782.
-
(2002)
Circulation
, vol.106
, pp. 1777-1782
-
-
Hillege, H.L.1
Fidler, V.2
Diercks, G.F.3
Van Gilst, W.H.4
De Zeeuw, D.5
Van Veldhuisen, D.J.6
Gans, R.O.7
Janssen, W.M.8
Grobbee, D.E.9
De Jong, P.E.10
-
18
-
-
34347364688
-
Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: The Hisayama Study
-
DOI 10.1161/STROKEAHA.106.479642
-
Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y. Impact of metabolic syndrome on the development of cardiovascular disease in a general japanese population: The hisayama study. Stroke 2007;38:2063-2069. (Pubitemid 47012268)
-
(2007)
Stroke
, vol.38
, Issue.7
, pp. 2063-2069
-
-
Ninomiya, T.1
Kubo, M.2
Doi, Y.3
Yonemoto, K.4
Tanizaki, Y.5
Rahman, M.6
Arima, H.7
Tsuryuya, K.8
Iida, M.9
Kiyohara, Y.10
-
19
-
-
58849107072
-
Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban japanese population: The suita study
-
Kokubo Y, Okamura T, Yoshimasa Y, Miyamoto Y, Kawanishi K, Kotani Y, Okayama A, Tomoike H. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban japanese population: The suita study. Hypertens Res 2008;31:2027-2035.
-
(2008)
Hypertens Res
, vol.31
, pp. 2027-2035
-
-
Kokubo, Y.1
Okamura, T.2
Yoshimasa, Y.3
Miyamoto, Y.4
Kawanishi, K.5
Kotani, Y.6
Okayama, A.7
Tomoike, H.8
-
20
-
-
0036792815
-
Prognostic relevance of early serial c-reactive protein measurements after first ischemic stroke
-
Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial c-reactive protein measurements after first ischemic stroke. Stroke 2002;33:2459-2464.
-
(2002)
Stroke
, vol.33
, pp. 2459-2464
-
-
Winbeck, K.1
Poppert, H.2
Etgen, T.3
Conrad, B.4
Sander, D.5
-
21
-
-
0348109424
-
Association between Blood Pressure and C-Reactive Protein Levels in Acute Ischemic Stroke
-
DOI 10.1161/01.HYP.0000100669.00771.6E
-
Di Napoli M, Papa F. Association between blood pressure and c-reactive protein levels in acute ischemic stroke. Hypertension 2003;42:1117-1123. (Pubitemid 37549065)
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1117-1123
-
-
Di Napoli, M.1
Papa, F.2
-
22
-
-
67349175342
-
Serum c-reactive protein levels can be used to predict future ischemic stroke and mortality in japanese men from the general population
-
Makita S, Nakamura M, Satoh K, Tanaka F, Onoda T, Kawamura K, Ohsawa M, Tanno K, Itai K, Sakata K, Okayama A, Terayama Y, Yoshida Y, Ogawa A. Serum c-reactive protein levels can be used to predict future ischemic stroke and mortality in japanese men from the general population. Atherosclerosis 2009;204:234-238.
-
(2009)
Atherosclerosis
, vol.204
, pp. 234-238
-
-
Makita, S.1
Nakamura, M.2
Satoh, K.3
Tanaka, F.4
Onoda, T.5
Kawamura, K.6
Ohsawa, M.7
Tanno, K.8
Itai, K.9
Sakata, K.10
Okayama, A.11
Terayama, Y.12
Yoshida, Y.13
Ogawa, A.14
-
23
-
-
0345490820
-
Direct Comparison of the Effects of Valsartan and Amlodipine on Renal Hemodynamics in Human Essential Hypertension
-
DOI 10.1016/j.amjhyper.2003.07.017
-
Delles C, Klingbeil AU, Schneider MP, Handrock R, Weidinger G, Schmieder RE. Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension. Am J Hypertens 2003;16:1030-1035. (Pubitemid 37500798)
-
(2003)
American Journal of Hypertension
, vol.16
, Issue.12
, pp. 1030-1035
-
-
Delles, C.1
Klingbeil, A.U.2
Schneider, M.P.3
Handrock, R.4
Weidinger, G.5
Schmieder, R.E.6
-
24
-
-
33745987893
-
Valsartan, blood pressure reduction, and c-reactive protein: Primary report of the val-marc trial
-
Ridker PM, Danielson E, Rifai N, Glynn RJ. Valsartan, blood pressure reduction, and c-reactive protein: Primary report of the val-marc trial. Hypertension 2006;48:73-79.
-
(2006)
Hypertension
, vol.48
, pp. 73-79
-
-
Ridker, P.M.1
Danielson, E.2
Rifai, N.3
Glynn, R.J.4
-
25
-
-
33645736670
-
Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation
-
discussion 770-761
-
Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, Ganda O, Ferran C, Veves A. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg 2006;43:760-770; discussion 770-761.
-
(2006)
J Vasc Surg
, vol.43
, pp. 760-770
-
-
Shrikhande, G.1
Khaodhiar, L.2
Scali, S.3
Lima, C.4
Hubbard, M.5
Dudley, K.6
Ganda, O.7
Ferran, C.8
Veves, A.9
-
26
-
-
33745841572
-
Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension
-
DOI 10.1080/10641960600798671, PII PQ2X8427X445U482
-
Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Gotoh A, Uchida K, Higaki J. Valsartan reduces serum cystatin c and the renal vascular resistance in patients with essential hypertension. Clin Exp Hypertens 2006;28:451-461. (Pubitemid 44034670)
-
(2006)
Clinical and Experimental Hypertension
, vol.28
, Issue.5
, pp. 451-461
-
-
Watanabe, S.1
Okura, T.2
Kurata, M.3
Irita, J.4
Manabe, S.5
Miyoshi, K.-I.6
Fukuoka, T.7
Gotoh, A.8
Uchida, K.9
Higaki, J.10
-
27
-
-
42349105620
-
Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension
-
DOI 10.1080/10641960802071000, PII 792293930
-
Hirooka Y, Kimura Y, Sagara Y, Ito K, Sunagawa K. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension. Clin Exp Hypertens 2008;30:267-276. (Pubitemid 351556172)
-
(2008)
Clinical and Experimental Hypertension
, vol.30
, Issue.3-4
, pp. 267-276
-
-
Hirooka, Y.1
Kimura, Y.2
Sagara, Y.3
Ito, K.4
Sunagawa, K.5
-
28
-
-
0037031270
-
Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect
-
DOI 10.1161/01.CIR.0000024416.33113.0A
-
Viberti G, Wheeldon NM. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect. Circulation 2002;106:672-678. (Pubitemid 34851925)
-
(2002)
Circulation
, vol.106
, Issue.6
, pp. 672-678
-
-
Viberti, G.1
Wheeldon, N.M.2
-
29
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
-
DOI 10.1007/BF00280883
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
-
(1985)
Diabetologia
, vol.28
, Issue.7
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
-
30
-
-
33947501000
-
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease
-
DOI 10.1007/s10157-006-0453-4
-
Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Estimation of glomerular filtration rate by the mdrd study equation modified for japanese patients with chronic kidney disease. Clin Exp Nephrol 2007;11:41-50. (Pubitemid 46474965)
-
(2007)
Clinical and Experimental Nephrology
, vol.11
, Issue.1
, pp. 41-50
-
-
Imai, E.1
Horio, M.2
Nitta, K.3
Yamagata, K.4
Iseki, K.5
Hara, S.6
Ura, N.7
Kiyohara, Y.8
Hirakata, H.9
Watanabe, T.10
Moriyama, T.11
Ando, Y.12
Inaguma, D.13
Narita, I.14
Iso, H.15
Wakai, K.16
Yasuda, Y.17
Tsukamoto, Y.18
Ito, S.19
Makino, H.20
Hishida, A.21
Matsuo, S.22
more..
-
31
-
-
55249087635
-
Genetically elevated c-reactive protein and ischemic vascular disease
-
Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated c-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-1908.
-
(2008)
N Engl J Med
, vol.359
, pp. 1897-1908
-
-
Zacho, J.1
Tybjaerg-Hansen, A.2
Jensen, J.S.3
Grande, P.4
Sillesen, H.5
Nordestgaard, B.G.6
-
32
-
-
0035876091
-
Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study
-
DOI 10.1093/aje/153.12.1183
-
Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E. Distribution of serum c-reactive protein and its association with atherosclerotic risk factors in a japanese population: Jichi medical school cohort study. Am J Epidemiol 2001;153:1183-1190. (Pubitemid 32552276)
-
(2001)
American Journal of Epidemiology
, vol.153
, Issue.12
, pp. 1183-1190
-
-
Yamada, S.1
Gotoh, T.2
Nakashima, Y.3
Kayaba, K.4
Ishikawa, S.5
Nago, N.6
Nakamura, Y.7
Itoh, Y.8
Kajii, E.9
-
33
-
-
8844239109
-
Association between serum C-reactive protein levels and microalbuminuria: A population-based cross-sectional study in Northern Iwate, Japan
-
DOI 10.2169/internalmedicine.43.919
-
Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A. Association between serum c-reactive protein levels and microalbuminuria: A population-based cross-sectional study in northern iwate, japan. Intern Med 2004;43:919-925. (Pubitemid 39534794)
-
(2004)
Internal Medicine
, vol.43
, Issue.10
, pp. 919-925
-
-
Nakamura, M.1
Onoda, T.2
Itai, K.3
Ohsawa, M.4
Satou, K.5
Sakai, T.6
Segawa, T.7
Sasaki, J.8
Tonari, Y.9
Hiramori, K.10
Okayama, A.11
-
34
-
-
33846470610
-
Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-α-induced monocyte chemoattractant protein-1 expression in endothelial cells
-
Matsui T, Yamagishi S, Nakamura K, Inoue H. Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-alpha-induced monocyte chemoattractant protein-1 expression in endothelial cells. J Int Med Res 2006; 34:671-675. (Pubitemid 46165392)
-
(2006)
Journal of International Medical Research
, vol.34
, Issue.6
, pp. 671-675
-
-
Matsui, T.1
Yamagishi, S.2
Nakamura, K.3
Inoue, H.4
-
35
-
-
48349097293
-
Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy
-
Ogawa S, Mori T, Nako K, Ito S. Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. Hypertens Res 2008;31:1147-1155.
-
(2008)
Hypertens Res
, vol.31
, pp. 1147-1155
-
-
Ogawa, S.1
Mori, T.2
Nako, K.3
Ito, S.4
-
36
-
-
70849104224
-
Genetic variation in the reninangiotensin system and arterial stiffness. The Rotterdam study
-
Sie MP, Yazdanpanah M, Mattace-Raso FU, Uitterlinden AG, Hofman A, Hoeks AP, Reneman RS, Asmar R, Van Duijn CM, Witteman JC. Genetic variation in the reninangiotensin system and arterial stiffness. The Rotterdam study. Clin Exp Hypertens 2009;31:389-399.
-
(2009)
Clin Exp Hypertens
, vol.31
, pp. 389-399
-
-
Sie, M.P.1
Yazdanpanah, M.2
Mattace-Raso, F.U.3
Uitterlinden, A.G.4
Hofman, A.5
Hoeks, A.P.6
Reneman, R.S.7
Asmar, R.8
Van Duijn, C.M.9
Witteman, J.C.10
-
37
-
-
47549083291
-
Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension
-
DOI 10.1080/10641960802279108, PII 795039442
-
Okura T, Watanabe S, Kurata M, Koresawa M, Irita J, Enomoto D, Jotoku M, Miyoshi K, Fukuoka T, Higaki J. Long-term effects of angiotensin ii receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension. Clin Exp Hypertens 2008;30:415-422. (Pubitemid 352009300)
-
(2008)
Clinical and Experimental Hypertension
, vol.30
, Issue.5
, pp. 415-422
-
-
Okura, T.1
Watanabe, S.2
Kurata, M.3
Koresawa, M.4
Irita, J.5
Enomoto, D.6
Jotoku, M.7
Miyoshi, K.-I.8
Fukuoka, T.9
Higaki, J.10
-
38
-
-
33947534858
-
Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop
-
DOI 10.1161/01.RES.0000259045.49371.9c, PII 0000301220070302000010
-
Yan C, Ding B, Shishido T, Woo CH, Itoh S, Jeon KI, Liu W, Xu H, McClain C, Molina CA, Blaxall BC, Abe J. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3a/inducible camp early repressor feedback loop. Circ Res 2007;100:510-519. (Pubitemid 46673260)
-
(2007)
Circulation Research
, vol.100
, Issue.4
, pp. 510-519
-
-
Yan, C.1
Ding, B.2
Shishido, T.3
Woo, C.-H.4
Itoh, S.5
Jeon, K.-I.6
Liu, W.7
Xu, H.8
McClain, C.9
Molina, C.A.10
Blaxall, B.C.11
Abe, J.-I.12
-
39
-
-
40949145324
-
Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells
-
DOI 10.1161/CIRCRESAHA.107.156877
-
Woo CH, Shishido T, McClain C, Lim JH, Li JD, Yang J, Yan C, Abe J. Extracellular signal-regulated kinase 5 sumoylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells. Circ Res 2008;102:538-545. (Pubitemid 351416753)
-
(2008)
Circulation Research
, vol.102
, Issue.5
, pp. 538-545
-
-
Woo, C.-H.1
Shishido, T.2
McClain, C.3
Lim, J.H.4
Li, J.-D.5
Yang, J.6
Yan, C.7
Abe, J.-I.8
-
40
-
-
44949114361
-
Effects of mek5/erk5 association on small ubiquitin- related modification of erk5: Implications for diabetic ventricular dysfunction after myocardial infarction
-
Shishido T, Woo CH, Ding B, McClain C, Molina CA, Yan C, Yang J, Abe J. Effects of mek5/erk5 association on small ubiquitin- related modification of erk5: Implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res 2008;102:1416-1425.
-
(2008)
Circ Res
, vol.102
, pp. 1416-1425
-
-
Shishido, T.1
Woo, C.H.2
Ding, B.3
McClain, C.4
Molina, C.A.5
Yan, C.6
Yang, J.7
Abe, J.8
-
41
-
-
9144236465
-
Chronic hypertriglyceridemia in young watanabe heritable hyperlipidemic rabbits impairs endothelial and medial smooth muscle function
-
DOI 10.1016/j.lfs.2003.08.018
-
Shishido T, Tasaki K, Takeishi Y, Takasaki S, Miyamoto T, Itoh M, Takahashi H, Kubota I, Ito T, Katano Y, Wakabayashi I, Tomoike H. Chronic hypertriglyceridemia in young watanabe heritable hyperlipidemic rabbits impairs endothelial and medial smooth muscle function. Life Sci 2004;74:1487-1501. (Pubitemid 38077211)
-
(2004)
Life Sciences
, vol.74
, Issue.12
, pp. 1487-1501
-
-
Shishido, T.1
Tasaki, K.2
Takeishi, Y.3
Takasaki, S.4
Miyamoto, T.5
Itoh, M.6
Takahashi, H.7
Kubota, I.8
Ito, T.9
Katano, Y.10
Wakabayashi, I.11
Tomoike, H.12
-
42
-
-
59649118742
-
Bcr kinase activation by angiotensin ii inhibits peroxisomeproliferator- activated receptor gamma transcriptional activity in vascular smooth muscle cells
-
Alexis JD, Wang N, Che W, Lerner-Marmarosh N, Sahni A, Korshunov VA, Zou Y, Ding B, Yan C, Berk BC, Abe J. Bcr kinase activation by angiotensin ii inhibits peroxisomeproliferator- activated receptor gamma transcriptional activity in vascular smooth muscle cells. Circ Res 2009;104: 69-78.
-
(2009)
Circ Res
, vol.104
, pp. 69-78
-
-
Alexis, J.D.1
Wang, N.2
Che, W.3
Lerner-Marmarosh, N.4
Sahni, A.5
Korshunov, V.A.6
Zou, Y.7
Ding, B.8
Yan, C.9
Berk, B.C.10
Abe, J.11
-
43
-
-
4444236607
-
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (SCOPE)
-
DOI 10.1016/j.jacc.2004.06.034, PII S0735109704012483
-
Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A. Stroke prevention with the angiotensin ii type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: The study on cognition and prognosis in the elderly (scope). J Am Coll Cardiol 2004;44: 1175-1180. (Pubitemid 39208870)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.6
, pp. 1175-1180
-
-
Papademetriou, V.1
Farsang, C.2
Elmfeldt, D.3
Hofman, A.4
Lithell, H.5
Olofsson, B.6
Skoog, I.7
Trenkwalder, P.8
Zanchetti, A.9
-
44
-
-
3242720779
-
Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease
-
DOI 10.1016/j.jacc.2004.03.065, PII S0735109704008460
-
Schieffer B, Bunte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, Drexler H. Comparative effects of at1- antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease. J Am Coll Cardiol 2004;44:362-368. (Pubitemid 38960662)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.2
, pp. 362-368
-
-
Schieffer, B.1
Bunte, C.2
Witte, J.3
Hoeper, K.4
Boger, R.H.5
Schwedhelm, E.6
Drexler, H.7
|